Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas E Johnson

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Neurology|April 14, 2019
FSHD1 or FSHD2: That is the question: The answer: It's all just FSHDNicholas E Johnson, Jeffrey M Statland
Seminars in Neurology|November 3, 2012
Myotonic dystrophy: from bench to bedsideNicholas E Johnson, Chad R Heatwole
Journal of Pediatric Rehabilitation Medicine|March 12, 2016
Neuromuscular DiseaseRussell J Butterfield, Nicholas E Johnson
Neurology|May 30, 2012
Noninvasive microscopic imaging of sensory receptors in neuropathyNicholas E Johnson, David N Herrmann
JAMA Neurology|January 1, 2016
Neurology Advocacy 2.0: After Sustainable Growth Rate RepealNicholas E Johnson, Amy Kaloides, Elaine Jones
JAMA|March 11, 2024
Diagnosis and Management of Myotonic Dystrophy Type 1Julia Hartman, Tejal Patki, Nicholas E Johnson
Journal of Multidisciplinary Healthcare|February 9, 2016
Management of Charcot-Marie-Tooth disease: improving long-term care with a multidisciplinary approachDonald McCorquodale, Evan M Pucillo, Nicholas E Johnson
Muscle & Nerve|January 26, 2013
Myotonia congenita in a patient who presented with diplopia and ptosisKaren Odrzywolski, Nicholas E Johnson, Paul T Twydell
The Journal of Pediatrics|March 20, 2013
New insights about the incidence, multisystem manifestations, and care of patients with congenital myotonic dystrophyJames E Hilbert, Nicholas E Johnson, Richard T Moxley
Journal of Clinical Neuromuscular Disease|November 19, 2016
Inclusion Body Myositis: What Most Impacts Patients' LivesCynthia Gibson, Nicholas E Johnson, Eileen Eastwood, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Neurology|April 14, 2019
FSHD1 or FSHD2: That is the question: The answer: It's all just FSHDNicholas E Johnson, Jeffrey M Statland
Seminars in Neurology|November 3, 2012
Myotonic dystrophy: from bench to bedsideNicholas E Johnson, Chad R Heatwole
Journal of Pediatric Rehabilitation Medicine|March 12, 2016
Neuromuscular DiseaseRussell J Butterfield, Nicholas E Johnson
Neurology|May 30, 2012
Noninvasive microscopic imaging of sensory receptors in neuropathyNicholas E Johnson, David N Herrmann
JAMA Neurology|January 1, 2016
Neurology Advocacy 2.0: After Sustainable Growth Rate RepealNicholas E Johnson, Amy Kaloides, Elaine Jones
JAMA|March 11, 2024
Diagnosis and Management of Myotonic Dystrophy Type 1Julia Hartman, Tejal Patki, Nicholas E Johnson
Journal of Multidisciplinary Healthcare|February 9, 2016
Management of Charcot-Marie-Tooth disease: improving long-term care with a multidisciplinary approachDonald McCorquodale, Evan M Pucillo, Nicholas E Johnson
Muscle & Nerve|January 26, 2013
Myotonia congenita in a patient who presented with diplopia and ptosisKaren Odrzywolski, Nicholas E Johnson, Paul T Twydell
The Journal of Pediatrics|March 20, 2013
New insights about the incidence, multisystem manifestations, and care of patients with congenital myotonic dystrophyJames E Hilbert, Nicholas E Johnson, Richard T Moxley
Journal of Clinical Neuromuscular Disease|November 19, 2016
Inclusion Body Myositis: What Most Impacts Patients' LivesCynthia Gibson, Nicholas E Johnson, Eileen Eastwood, et al.
Pageof 11